desogestrel has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appiah, L; Foust, E; Hassell, K; Murray, S; Polotsky, AJ; Roeca, C; Rushing, JS | 1 |
| Freeman, S; Shulman, LP | 1 |
1 review(s) available for desogestrel and Benign Neoplasms
| Article | Year |
|---|---|
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
1 other study(ies) available for desogestrel and Benign Neoplasms
| Article | Year |
|---|---|
Ovarian stimulation for fertility preservation in an oncology patient with etonogestrel implant in place.
Topics: Adult; Anti-Mullerian Hormone; Cryopreservation; Desogestrel; Female; Fertility Preservation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Luteinizing Hormone; Neoplasms; Oocyte Retrieval; Oocytes; Oogenesis; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Prostheses and Implants; Vitrification | 2021 |